Advertisement
Berita Valas
South Korea Bourse May Extend Monday's Losses
The South Korea stock market has finished lower in two of three trading days since the end of the four-day winning streak in which it had soared almost 100 points or 4 percent. The KOSPI now rests just beneath the 2,475-point plateau and it may take further damage on Tuesday.
RTTNews |
1001 days ago
TSX Sheds Nearly 1%
The Canadian market ended notably lower on Monday, weighed down by sharp losses in healthcare, technology, energy and utilities sections.
RTTNews
|
1001 days ago
Japan GDP Data On Tap For Tuesday
Japan will on Tuesday release preliminary Q3 numbers for gross domestic product, highlighting a busy day for Asia-Pacific economic activity. GDP is expected to rose 0.3 percent on quarter and 1.1 percent on year after gaining 0.9 percent on quarter and 3.5 percent on year in the second quarter.
RTTNews
|
1001 days ago
South Korea Export Prices Climb 13.7% On Year In October
Export prices in South Korea were up 13.7 percent on year in October, the Bank of Korea said on Tuesday - slowing from 14.7 percent in September.
RTTNews
|
1002 days ago
Swiss Market Ends Notably Lower
The Switzerland stock market ended notably lower on Monday, bucking the largely positive trend in most of the markets across Europe.
RTTNews
|
1002 days ago
European Stocks Close Broadly Higher
European stocks closed broadly higher on Monday with investors reacting positively to news about China unveiling a sweeping rescue package to salvage its real estate market.
RTTNews
|
1002 days ago
Canadian Market Down In Negative Territory In Cautious Trade
The Canadian market, which opened lower, continues to languish in negative territory in late morning trades on Monday, weighed down by losses in healthcare, technology and utilities shares.
RTTNews
|
1002 days ago
more news
Moderna Says Both Bivalent Omicron-targeting Booster Candidates Trigger Superior Antibody Response
Biotechnology company Moderna, Inc. (MRNA) announced Monday that both of Moderna's bivalent Omicron-targeting booster candidates, mRNA-1273.214 and mRNA-1273.222, trigger a superior antibody response compared to a booster dose of mRNA-1273, the Company's prototype vaccine, against Omicron (BA.4/BA.5) in Phase 2/3 clinical trials.
RTTNews
|
1002 days ago
Valmont Industries To Divest Offshore Wind Business To Euro Steel
Valmont Industries, Inc. (VMI) announced Monday that the Company has entered into a definitive agreement to sell its offshore wind business to Euro Steel, a Denmark-based supplier of steel products to the European wind market.
RTTNews
|
1002 days ago
Bay Street Likely To Open On Weak Note
Canadian shares are likely to open on a negative note on Monday, tracking weak commodity prices. The mood is likely to remain cautious with investors assessing the prospects of the Federal Reserve slowing down the pace of its interest rate hikes.
RTTNews
|
1002 days ago
Yen Losing Ground Against Majors
The Japanese yen dropped against its major counterparts in the European session on Monday, amid a divergence in monetary policies between the U.S. Federal Reserve and the Bank of Japan.
RTTNews
|
1002 days ago
AECOM Guides FY23 Adj. EPS In Line With Estimates - Update
While reporting financial results for the fourth quarter on Monday, infrastructure consulting firm AECOM (ACM) initiated adjusted earnings and organic net service revenue growth outlook for the full-year 2023.
RTTNews
|
1002 days ago
Protalix Resubmits To FDA The BLA For Pegunigalsidase Alfa For Treatment Of Fabry Disease
Biopharmaceutical company Protalix BioTherapeutics, Inc. (PLX) announced Monday the resubmission on Wednesday of a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for PRX-102 (pegunigalsidase alfa) for the treatment of adult patients with Fabry disease.
RTTNews
|
1002 days ago
Stay up to date!
Add Berita to your browser
Add To Chrome
